CANF Gross Profit Growth
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Gross Profit Growth
CANF Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported-27.68%period ending
CANF TTM Gross Profit YoY % (-57.27% → -27.68%)
Year-over-year change
High-resolution chart · PNG
CANF gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| -27.6786% | |
| -34.3598% | |
| -39.911% | |
| -25.7692% | |
| -16.042% | |
| -12.4823% | |
| -9.2867% | |
| -17.1975% | |
| -15.889% | |
| -11.985% | |
| -8.2716% | |
| -3.9168% | |
| -8.2176% | |
| -11.978% | |
| -5.041% | |
| 2.2528% | |
| 13.834% | |
| 27.6297% | |
| 11.7955% | |
| -0.7453% | |
| -56.5292% | |
| -63.0761% | |
| -62.4508% | |
| -62.1888% | |
| -51.5807% | |
| -44.6229% | |
| -46.8063% | |
| -41.447% | |
| 126.2341% | |
| 148.48% | |
| 352.2075% | |
| 392.7132% | |
| 654.2583% | |
| 653.2349% | |
| 398.3765% | |
| 272.1635% | |
| 3.5823% | |
| -15.8203% | |
| 2.904% | |
| 44.0122% | |
| 184.5477% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -78.9375% | |
| -57.2662% |